| Identification | |
| Name: | 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-9,10-dihydro-6,11-dihydroxy-8-(hydroxyacetyl)-1-methoxy-,(S)- (9CI) |
| Synonyms: | 9,10-anhydroadriamycin |
| CAS: | 80996-23-2 |
| Molecular Formula: | C27H27 N O10 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C27H27NO10/c1-10-23(31)14(28)8-18(37-10)38-17-7-11(15(30)9-29)6-13-20(17)27(35)22-21(25(13)33)24(32)12-4-3-5-16(36-2)19(12)26(22)34/h3-6,10,14,17-18,23,29,31,33,35H,7-9,28H2,1-2H3/t10-,14-,17-,18-,23+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 430.8°C |
| Boiling Point: | 788.7°C at 760 mmHg |
| Density: | 1.58g/cm3 |
| Refractive index: | 1.708 |
| Flash Point: | 430.8°C |
| Usage: | Doxorubicin (D558000) analog as antitumor |
| Safety Data | |
 |
|
